The accumulation of mutant fibroblast growth factor receptor 3 (FGFR3) in the endoplasmic reticulum of chondrocytic cells and their apoptosis

被引：0
|
作者：
Nasu, M
Amizuka, N
Li, M
Nomura, S
Henderson, JE
Maeda, T
机构：
[1] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Biol Sci, Div Oral Anat, Niigata 95021, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Oral Hlth Aging & Fixed Prosthodont, Niigata 95021, Japan
[3] McGill Univ, Ctr Bone & Periodontal Res, Montreal, PQ H3A 2T5, Canada
来源：
BONE | 2005年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [31] Acanthosis nigricans in hypochondroplasy with fibroblast growth factor receptor 3 (FGFR3) mutation Lys650ln
    Nowak, J.
    Schuler, G.
    Simon, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 243 - 243
  • [32] PATHOLOGICAL VALIDATION OF ADJUVANT ANTI - FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR PERSONALIZED TREATMENT OF BLADDER CANCER
    Neuzillet, Yann
    Mertens, Laura
    Shariat, Shahrokh
    Bostrom, Peter
    Mirtti, Tuomas
    Sagalowsky, Arthur
    Ashfaq, Raheela
    Broeks, Annegien
    Michiel Van
    Der Heijden
    Peters, Dennis
    Curial, Chantall
    De Jong, Jeroen
    Horenblas, Simon
    Hurst, Carolyn
    Tomlinson, Darren
    Knowles, Margaret
    Bapat, Bharati
    Jewett, Michael
    Zlotta, Alexandre
    Sanders, Joyce
    Lotan, Yair
    Van der Kwast, Theo
    Van Rhijn, Bas
    JOURNAL OF UROLOGY, 2014, 191 (04): : E304 - E304
  • [33] FIBROBLAST-GROWTH-FACTOR-RECEPTOR-3 (FGFR3) TRANSMEMBRANE MUTATION IN CROUZON-SYNDROME WITH ACANTHOSIS NIGRICANS
    MEYERS, GA
    ORLOW, SJ
    MUNRO, IR
    PRZYLEPA, KA
    JABS, EW
    NATURE GENETICS, 1995, 11 (04) : 462 - 464
  • [34] Hypochondroplasia, achondroplasia, and thanatophoric dysplasia caused by mutations of the fibroblast-growth-factor-receptor-3-gene (FGFR3)
    Hilbert, M
    Hilbert, K
    Spranger, J
    Wildhardt, G
    Winterpacht, A
    Wuchner, C
    Zabel, B
    MONATSSCHRIFT KINDERHEILKUNDE, 1998, 146 (07) : 687 - 691
  • [35] A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome
    Muenke, M
    Gripp, KW
    McDonaldMcGinn, DM
    Gaudenz, K
    Whitaker, LA
    Bartlett, SP
    Markowitz, RI
    Robin, NH
    Nwokoro, N
    Mulvihill, JJ
    Losken, HW
    Mulliken, JB
    Guttmacher, AE
    Wilroy, RS
    Clarke, LA
    Hollway, G
    Ades, LC
    Haan, EA
    Mulley, JC
    Cohen, MM
    Bellus, GA
    Francomano, CA
    Moloney, DM
    Wall, SA
    Wilkie, AOM
    Zackai, EH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (03) : 555 - 564
  • [36] Fibroblast growth factor receptor 3 (FGFR3) Lys650Asn mutation causes hypochondroplasia.
    Bellus, GA
    Speiser, PW
    Webster, MK
    Donoghue, DJ
    Francomano, CA
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A283 - A283
  • [37] Sixteen Years and Counting: The Current Understanding of Fibroblast Growth Factor Receptor 3 (FGFR3) Signaling in Skeletal Dysplasias
    Foldynova-Trantirkova, Silvie
    Wilcox, William R.
    Krejci, Pavel
    HUMAN MUTATION, 2012, 33 (01) : 29 - 41
  • [38] THE FIBROBLAST GROWTH-FACTOR RECEPTOR-3 GENE (FGFR3) IS ASSIGNED TO HUMAN CHROMOSOME-4
    KEEGAN, K
    ROOKE, L
    HAYMAN, M
    SPURR, NK
    CYTOGENETICS AND CELL GENETICS, 1993, 62 (2-3): : 172 - 175
  • [39] NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells
    Chlebova, Katarina
    Krejci, Pavel
    FASEB JOURNAL, 2010, 24
  • [40] NF449 Is a Novel Inhibitor of Fibroblast Growth Factor Receptor 3 (FGFR3) Signaling Active in Chondrocytes and Multiple Myeloma Cells
    Krejci, Pavel
    Murakami, Shunichi
    Prochazkova, Jirina
    Trantirek, Lukas
    Chlebova, Katarina
    Ouyang, Zhufeng
    Aklian, Anie
    Smutny, Jiri
    Bryja, Vitezslav
    Kozubik, Alois
    Wilcox, William R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (27) : 20644 - 20653
12345